A Case of Pseudoxanthoma Elasticum with Juvenile-onset Hypertension.

Intern Med

Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan.

Published: November 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637802PMC
http://dx.doi.org/10.2169/internalmedicine.3050-23DOI Listing

Publication Analysis

Top Keywords

case pseudoxanthoma
4
pseudoxanthoma elasticum
4
elasticum juvenile-onset
4
juvenile-onset hypertension
4
case
1
elasticum
1
juvenile-onset
1
hypertension
1

Similar Publications

Background: Pseudoxanthoma elasticum (PXE) is characterized by aberrant calcification of elastic tissues throughout the body causing varying degrees of skin, cardiac, and ocular disease. Although PXE is classically regarded as an autosomal recessive disease, recent reports have demonstrated a haploinsufficiency phenotype, in which carriers of monoallelic ATP-binding cassette transporter () gene mutations demonstrate mild manifestations of PXE. In this case report, we describe a patient with a monoallelic mutation and atypical angioid streaks.

View Article and Find Full Text PDF

Background/aim: Pseudoxanthoma elasticum (PXE) is a genetic connective tissue disorder that affects the skin with limited treatment options. A recent technology employing particle-free polycaprolactone (PCL) has shown promising results in treating inner thighs and kness of a 27-year-old female patient. This article provides a case report along with our detailed treatment protocol based on the efficacy of PCL in reversing skin laxity that can be easily incorporated into the therapeutic approaches for patients with PXE.

View Article and Find Full Text PDF

Pseudoxanthoma elasticum-like papillary dermal elastolysis; A report of two cases and a literature review.

Dermatol Online J

October 2024

Division of Dermatology, Department of Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Pseudoxanthoma elasticum-like papillary dermal elastolysis is a rare, benign, acquired, gradually-developing chronic elastic tissue disorder that almost exclusively affects post-menopausal women. It is essential to recognize this disease as it mimics the inherited pseudoxanthoma clinically. The pathophysiology behind this disease is multifactorial; it includes intrinsic skin aging, ultraviolet radiation exposure, and genetic components.

View Article and Find Full Text PDF

Fibroelastolytic papulosis (FEP) is an acquired cutaneous disorder of elastin that encompasses both white fibrous papulosis of the neck (WFPN) and pseudoxanthoma elasticum (PXE)-like papillary dermal elastolysis (PDE). Although FEP is a benign acquired disorder, it shares overlapping clinical features with pseudoxanthoma elasticum (PXE), a genetic disorder with systemic manifestations. We report two cases of FEP, including the WFPN and PXE-like PDE variants, in elderly women.

View Article and Find Full Text PDF

Successful Pedal Bypass in a Patient With Pseudoxanthoma Elasticum.

Vasc Endovascular Surg

October 2024

Department of Internal Medicine, Tampere University Hospital, Faculty of Medicine and Life Sciences, Tampere, Finland.

Article Synopsis
  • Pseudoxanthoma elasticum (PXE) is a rare condition that leads to deep calcification in arteries, often resulting in peripheral artery disease (PAD), which poses challenges in surgical treatments.
  • A case report details a successful treatment of a 57-year-old female with PXE who suffered from critical limb ischemia (CLI), using a pedal bypass with the great saphenous vein after unsuccessful angioplasty.
  • The patient showed significant improvement at the one-month follow-up, with almost healed ulcerations and uncomplicated results in subsequent ultrasounds, emphasizing the importance of timely surgery and a collaborative medical approach for managing PAD in PXE patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!